So you’ve decided to go on a GLP-1 to lose weight. These medicines might seem like an easy way to drop unwanted pounds, but you’ll likely need to do a few other things to be successful long-term.

Last month, the FDA rejected a Hunter syndrome gene therapy from Regenxbio over a lack of clinical data. Denali Therapeutics' drug is a form of enzyme replacement therapy — not a gene therapy — that ...

Seven cases are under investigation; all of the people involved were unvaccinated against measles, CBS News reported. The emergency room treatment area of Trinity Health Ann Arbor Hospital in ...

Jurors ruled that Meta and YouTube were negligent and awarded the plaintiff $6 million in damages. Meanwhile, The New York Times reports on an Irish village making a "phone-free childhood" happen.

The insurers are accused of paying to have customers directed to their Medicare Advantage plans and of paying brokers to limit sign-ups of people with disabilities. The companies deny any wrongdoing.

The company Cord Blood Registry is being sued by the attorneys general of Texas and Arizona over claims about the medical value of storing newborn cord blood, while charging new parents thousands of ...

Jay Bhattacharya will continue to lead the agency while the administration searches for a permanent director. About six contenders are still under consideration, The Washington Post reports. Also, a ...

Jay Bhattacharya, head of the National Institutes of Health and interim leader of the Centers for Disease Control and Prevention, told staff a permanent CDC director could be nominated soon. “I know ...

Thousands of employees are gone and last summer’s shooting resonates still at the Centers for Disease Control and Prevention ...

The administration has largely converted the HHS Office of Refugee Resettlement into an arm of immigration enforcement, ...

Adults ages 50 through 64 faced some of the steepest increases in out-of-pocket costs for Obamacare plans after a set of ...

The rapidly growing company will spend $2 billion on the suburban Atlanta plant, marking a major expansion into the U.S. Other industry news is on insulin pricing, doctors' drug kickbacks, and more.